MENUNews Archive
Date: 05/20/2020
A new analytic tool developed by University of Michigan Rogel Cancer Center researchers combines multiple data sets to help sift the signal from the noise. Called transPRECISE, it can identify pre-clinical systems or potential treatments for multiple cancer types
Date: 05/13/2020
During the holy month this year, public health experts from the University of Michigan Rogel Cancer Center are partnering with the Dearborn-based nonprofit ACCESS on a culturally tailored smoking cessation campaign called Yallah Quit. Yallah is Arabic for “Let’s go!”
Date: 05/06/2020
The Forbes Institute for Cancer Research at the University of Michigan Rogel Cancer Center will fund two researchers pursuing promising new treatment approaches for brain and ovarian cancers. Maria G. Castro, Ph.D., and Deepak Nagrath, Ph.D., will receive one-year grants of $250,000 each as 2020 Forbes Scholars.
Date: 04/30/2020
A team of scientists led by the University of Michigan Rogel Cancer Center and Case Comprehensive Cancer Center has identified the binding site where drug compounds could activate a key braking mechanism against the runaway growth of many types of cancer.
Date: 04/30/2020
About a third of advanced prostate cancers don’t respond to drugs like enzalutamide. A multi-institutional clinical trial is shedding new light on these non-responsive tumors -- pointing toward unique molecular characteristics that might be targetable with new therapeutic approaches.
Date: 04/28/2020
With no national data source, a University of Michigan-led study has uncovered frequent spills, inconsistent PPE use and problems with closed-system transfer devices across 12 institutions.
Date: 04/28/2020
Drs. Arul Chinnaiyan and Janet Smith, both members of the Rogel Cancer Center, were among four University of Michigan professors elected to the National Academy of Sciences.
Date: 04/22/2020
Some types of gut bacteria are better than others at stimulating certain immune cells, specifically CD8+ T cells, in the body, they found.
Date: 04/22/2020
Using next-generation RNA sequencing techniques, a team of scientists from the University of Michigan Rogel Cancer Center has uncovered the gene signature of chromophobe renal cell carcinoma (ChRCC) and have extensively tested the expression of three new biomarkers.
Date: 04/17/2020
As health care organizations move to create policies and training to eliminate gender bias and harassment, medical ethicists argue that it’s not enough.